Что делать при увеличенной простате? Способы уменьшения простаты и последствия

Key takeaways: how to approach enlarged prostate (BPH) safely

• Treat the person, not the ultrasound alone

  • Treatment decisions should be driven by your symptoms/complaints, not just the number on a report.

• Size alone is not the criterion

  • Prostate size varies by age and individual anatomy.
  • The presenter warns against automatically concluding “operation because it’s enlarged.”

• Check what’s actually going on (common diagnostic traps)

  • Prostate may be smaller yet still cause weak urine flow
    • The video distinguishes this possibility from prostatitis and suggests prostatic sclerosis as one cause of weak stream.
  • Prostatitis diagnosis vs urinary obstruction
    • The presenter argues that prostatitis should not automatically be treated as the cause of weak urinary stream.
    • A weak stream may point to other mechanisms (e.g., sclerosis).
  • Middle lobe issues
    • Sometimes a middle lobe can behave like a valve/compression, even if overall prostate size isn’t the “worst.”
    • Post-op failure can occur if the middle lobe was missed or left behind.

• Use objective symptom severity markers

  • Residual urine
    • Operation is discussed as more likely when residual urine > ~50 ml (and higher values suggest more severe outflow obstruction).
  • Uroflowmetry
    • Assess urine flow quality.
    • The presenter advises caution if treatment is suggested without measuring flow.
  • IPSS questionnaire
    • Use the IPSS to self-assess symptom severity and track changes before/after treatment.

---

Treatment strategy (least → most invasive)

1) Watchful waiting (no immediate intervention)

• Default approach when there are no meaningful complaints.

2) Drug therapy (five approaches mentioned)

Alpha-blockers (symptomatic)

• Improve urination quality, but do not “cure” gland enlargement.
• Notes/possible effects mentioned:
  • Retrograde ejaculation (sperm goes toward the bladder during intercourse; returns after stopping)
  • Some can lower blood pressure
• Monitoring warning (presenter’s view):
  • Long-term use may allow progression to very large glands that eventually require surgery, so recheck prostate size/dynamics.

5-alpha reductase inhibitors (hormonal shrinking effect)

• Intended to reduce prostate volume over time.
• Considered when:
  • Surgery isn’t desired or is contraindicated (e.g., age, recent heart attack/stroke, etc.)
  • Sometimes used to reduce size beforehand to make procedures easier
• Important PSA/oncology warning:
  • The presenter states these drugs can halve PSA levels, potentially masking early prostate cancer unless PSA is interpreted correctly.

Hormonal-level “shrinking” drugs (inhibitor-type)

• Described as shrinking therapy by targeting hormones as an alternative to surgery.

Anti-inflammatory therapy / suppositories

• Intended to reduce swelling and urinary complaints.
• The presenter claims many “herbal” ads act mostly symptomatically by reducing swelling rather than eliminating adenoma.

Another drug category referenced via “erection pills”

• The presenter references a drug class commonly known from erectile dysfunction contexts as relevant to prostate therapy in the talk.
• General advice: prostate size still needs monitoring.

3) Surgery (last resort)

• Presented as the option when no alternatives remain, especially with severe obstruction or failure of other approaches.

---

Wellness / self-care & lifestyle strategies emphasized

• Physical activity to support pelvic blood flow

  • Regular movement; avoid sitting all day.
  • Suggestions include walking and swimming.
  • On long flights: squats/walking as a preventive measure (mentioned as helping reduce thrombosis risk).

• Kegel exercises

  • Recommended as part of prevention/support to reduce flare-ups and urinary/pelvic issues.

• Hydration

  • Encourage avoiding dehydration to reduce risk of urinary problems.

• Be careful with physiotherapy and massage

  • Avoid massage/physiotherapy in acute or purulent prostatitis (contraindicated).
  • If there are calcifications “stuffing” in the gland, massage is also contraindicated.
  • The presenter says physiotherapy/massage can be reasonable when indicated (e.g., swelling or stagnation)—but only with correct diagnosis.

• Recognize that rapid “growth” can be swelling

  • The presenter claims prostate volume can seem to jump quickly due to inflammation/swelling, not true adenoma growth.
  • If worsening is sudden, treatments that reduce swelling/blood congestion may help (in the presenter’s view).

---

Natural remedies / supplements discussed (herbs and claimed mechanisms)

The presenter lists common natural ingredients and frames them as supported by research/experience, primarily for anti-inflammatory and microcirculation effects (not guaranteed cures):

• Pumpkin seeds / pumpkin seed oil
  • Suggested dose: ~10 g/day
• Saw palmetto (dwarf palm)
  • Suggested to support better bladder emptying; described as anti-inflammatory
• African plum extract
  • Suggested dose: ~200 mg/day to improve urination adequacy
• Babassu palm oil
  • Traditionally used; claimed to help urination
• Lycopene (tomatoes)
  • Mentioned as anti-inflammatory and supportive of microcirculation/hormonal balance

---

Psychological / communication guidance included

• TRUS anxiety coping advice
  • Reduce discomfort by:
    • Relaxing and lying in the same position used for the procedure
    • Deep breathing
    • Not resisting, because resistance increases pain

---

Presenters / Sources

• Presenter: Unspecified male doctor/urologist (speaking directly in the subtitles; no name provided).
• Referenced tools/documents:
  • IPSS questionnaire
  • PSA (prostate-specific antigen)
  • Ultrasound types: transabdominal, TRUS/transrectal
  • Uroflowmetry
• Research evidence mentioned:
  • General reference to “analysis today of what is confirmed by research,” without specific study citations in the provided subtitles.